Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
249 questions in 68 reviews · Airways
current versionsNo studies 249 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Antibiotics vs placebo or usual care Relapse after index presentation ‐ not reported · acute asthma exacerbation Antibiotics for exacerbations of asthma (2018) · Cochrane | no estimate extracted | NR | No studies |
Nurse‐led care vs doctor‐led care Emergency department attendance · management of bronchiectasis Nurse‐led versus doctor‐led care for bronchiectasis (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adults and adolescents · adults and children with chronic asthma Inhaled steroids with and without regular salmeterol for asthma: serious adverse events (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Children · adults and children with chronic asthma Inhaled steroids with and without regular salmeterol for asthma: serious adverse events (2018) · Cochrane | no estimate extracted | NR | No studies |
NMES and exercise vs exercise (with or without sham NMES) Peripheral muscle endurance/fatigability · COPD Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease (2018) · Cochrane | no estimate extracted | NR | No studies |
NMES and exercise vs exercise (with or without sham NMES) Thigh muscle size · COPD Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease (2018) · Cochrane | no estimate extracted | NR | No studies |
NMES vs usual care (with or without sham NMES) Functional performance · COPD Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Once‐daily ICS/LABA combined inhalers vs once‐daily LAMA Exacerbations leading to intubation · people with chronic obstructive pulmonary disease Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting… (2018) · Cochrane | no estimate extracted | NR | No studies |
Once‐daily ICS/LABA combined inhalers vs once‐daily LAMA Physical activity measure (e.g. 6MWT) · people with chronic obstructive pulmonary disease Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting… (2018) · Cochrane | no estimate extracted | NR | No studies |
Behavioural intervention vs usual care Exacerbations · autumn asthma exacerbations in children Interventions for autumn exacerbations of asthma in children (2018) · Cochrane | no estimate extracted | NR | No studies |
Behavioural intervention vs usual care Adverse events · autumn asthma exacerbations in children Interventions for autumn exacerbations of asthma in children (2018) · Cochrane | no estimate extracted | NR | No studies |
Leukotriene receptor antagonist vs usual care Exacerbations · autumn asthma exacerbations in children Interventions for autumn exacerbations of asthma in children (2018) · Cochrane | no estimate extracted | NR | No studies |
Macrolides vs placebo Quality of life not reported · children with bronchiectasis Macrolide antibiotics for bronchiectasis (2018) · Cochrane | no estimate extracted | NR | No studies |
Macrolides vs no intervention Exacerbations ‐ not reported · children with bronchiectasis Macrolide antibiotics for bronchiectasis (2018) · Cochrane | no estimate extracted | NR | No studies |
Macrolides vs no intervention Hospitalisation ‐ not reported · children with bronchiectasis Macrolide antibiotics for bronchiectasis (2018) · Cochrane | no estimate extracted | NR | No studies |
Macrolides vs no intervention Serious adverse events ‐ not reported · children with bronchiectasis Macrolide antibiotics for bronchiectasis (2018) · Cochrane | no estimate extracted | NR | No studies |
Macrolides vs no intervention Quality of life ‐ not reported · children with bronchiectasis Macrolide antibiotics for bronchiectasis (2018) · Cochrane | no estimate extracted | NR | No studies |
Macrolides vs no intervention Hospitalisations ‐ not reported · adults with bronchiectasis Macrolide antibiotics for bronchiectasis (2018) · Cochrane | no estimate extracted | NR | No studies |
Macrolides vs no intervention Serious adverse events ‐ not reported · adults with bronchiectasis Macrolide antibiotics for bronchiectasis (2018) · Cochrane | no estimate extracted | NR | No studies |
Self‐management vs usual care Exacerbations requiring antibiotics · people with non‐cystic fibrosis bronchiectasis Self‐management for bronchiectasis (2018) · Cochrane | no estimate extracted | NR | No studies |
Self‐management vs usual care Economic costs · people with non‐cystic fibrosis bronchiectasis Self‐management for bronchiectasis (2018) · Cochrane | no estimate extracted | NR | No studies |
Fluoroquinolones vs amoxicillin Exacerbations · adults aged 18 years and above with diagnosis of non‐cystic fibrosis bronchiectasis Head‐to‐head trials of antibiotics for bronchiectasis (2018) · Cochrane | no estimate extracted | NR | No studies |
Polymyxins vs aminoglycosides Quality of life · adults aged 18 years and above with diagnosis of bronchiectasis Head‐to‐head trials of antibiotics for bronchiectasis (2018) · Cochrane | no estimate extracted | NR | No studies |
Fluoroquinolones vs amoxicillin Quality of life · adults aged 18 years and above with diagnosis of non‐cystic fibrosis bronchiectasis Head‐to‐head trials of antibiotics for bronchiectasis (2018) · Cochrane | no estimate extracted | NR | No studies |
Polymyxins vs aminoglycosides Exacerbation · adults aged 18 years and above with diagnosis of bronchiectasis Head‐to‐head trials of antibiotics for bronchiectasis (2018) · Cochrane | no estimate extracted | NR | No studies |
MgSO4 vs SABA Lung function · adults and children with acute exacerbation of asthma Inhaled magnesium sulfate in the treatment of acute asthma (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Incidence of acute exacerbations of bronchiectasis ‐ not reported · people with bronchiectasis Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Duration of acute exacerbation of bronchiectasis ‐ not reported · people with bronchiectasis Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Incidence of hospitalisation ‐ not reported · people with bronchiectasis Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis (2017) · Cochrane | no estimate extracted | NR | No studies |
ICS dose reduction vs no change Steroid‐related AEs ‐ not reported · adults with asthma Stepping down the dose of inhaled corticosteroids for adults with asthma (2017) · Cochrane | no estimate extracted | NR | No studies |
ICS dose reduction vs no change Exacerbations requiring hospitalisation ‐ not reported · adults with asthma Stepping down the dose of inhaled corticosteroids for adults with asthma (2017) · Cochrane | no estimate extracted | NR | No studies |
PAAP plus education vs education alone Serious adverse events (including death). · adults with asthma Personalised asthma action plans for adults with asthma (2017) · Cochrane | no estimate extracted | NR | No studies |
PAAP plus education vs education alone Lung function. · adults with asthma Personalised asthma action plans for adults with asthma (2017) · Cochrane | no estimate extracted | NR | No studies |
PAAP plus education vs education alone Days lost from work or study. · adults with asthma Personalised asthma action plans for adults with asthma (2017) · Cochrane | no estimate extracted | NR | No studies |
Airway bypass stents vs control Cost effectiveness · Participants suffering from chronic obstructive pulmonary disease Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease (2017) · Cochrane | no estimate extracted | NR | No studies |
Intrabronchial valves vs control Cost‐ effectiveness · Participants suffering from chronic obstructive pulmonary disease Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease (2017) · Cochrane | no estimate extracted | NR | No studies |
AeriSeal vs control Change from baseline in lung function parameters other than FEV1 · Participants suffering from chronic obstructive pulmonary disease Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease (2017) · Cochrane | no estimate extracted | NR | No studies |
Vapour ablation vs control Cost effectiveness · Participants suffering from chronic obstructive pulmonary disease Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease (2017) · Cochrane | no estimate extracted | NR | No studies |
AeriSeal vs control Cost effectiveness end of · Participants suffering from chronic obstructive pulmonary disease Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease (2017) · Cochrane | no estimate extracted | NR | No studies |
Multimedia training vs control versus usual care Other outcomes · adults and children with asthma Interventions to improve inhaler technique for people with asthma (2017) · Cochrane | no estimate extracted | NR | No studies |
Feedback device vs control versus usual care Other outcomes · adults and children with asthma Interventions to improve inhaler technique for people with asthma (2017) · Cochrane | no estimate extracted | NR | No studies |
Enhanced education vs control versus usual care Other outcomes · adults and children with asthma Interventions to improve inhaler technique for people with asthma (2017) · Cochrane | no estimate extracted | NR | No studies |
Shared decision‐making vs usual care Parent/patient satisfaction · adults and children with asthma Shared decision‐making for people with asthma (2017) · Cochrane | no estimate extracted | NR | No studies |
Shared decision‐making vs usual care Adverse events (all) · adults and children with asthma Shared decision‐making for people with asthma (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events · adolescents with asthma Lay‐led and peer support interventions for adolescents with asthma (2017) · Cochrane | no estimate extracted | NR | No studies |
Tai Chi and breathing exercise vs breathing exercise CI: Confidence interval · chronic obstructive pulmonary disease (COPD) Tai Chi for chronic obstructive pulmonary disease (COPD) (2016) · Cochrane | no estimate extracted | NR | No studies |
Tai Chi and exercise vs exercise CI: Confidence interval · chronic obstructive pulmonary disease (COPD) Tai Chi for chronic obstructive pulmonary disease (COPD) (2016) · Cochrane | no estimate extracted | NR | No studies |
Tai Chi vs usual care CI: Confidence interval · chronic obstructive pulmonary disease (COPD) Tai Chi for chronic obstructive pulmonary disease (COPD) (2016) · Cochrane | no estimate extracted | NR | No studies |
Breathing exercises as part of a package of interventions vs control Serious adverse events · children with asthma Breathing exercises for children with asthma (2016) · Cochrane | no estimate extracted | NR | No studies |
Cognitive behavioural therapy vs usual care Asthma exacerbations requiring at least a course of oral steroids · adults and adolescents with asthma Cognitive behavioural therapy (CBT) for adults and adolescents with asthma (2016) · Cochrane | no estimate extracted | NR | No studies |